IO Biotech Ownership | Who Owns IO Biotech?
IO Biotech Ownership Summary
IO Biotech is owned by 2.11% institutional investors, 5.15% insiders, and 92.75% retail investors. Novo is the largest institutional shareholder, holding 3.81% of IOBT shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 5.48% of its assets in IO Biotech shares.
IOBT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | IO Biotech | 2.11% | 5.15% | 92.75% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Novo | 2.51M | 3.81% | $912.27K |
| Bank of america corp /de/ | 1.65M | 2.51% | $1.93M |
| Ikarian capital | 1.53M | 2.32% | $554.05K |
| Marshall wace, llp | 1.05M | 1.60% | $378.95K |
| Alyeska investment group | 987.65K | 1.50% | $1.16M |
| Boothbay fund management | 591.18K | 0.90% | $214.66K |
| Morgan stanley | 539.18K | 0.81% | $328.31K |
| Gsa capital partners llp | 348.35K | 0.52% | $20.00K |
| Point72 asset management | 250.00K | 0.38% | $90.78K |
| Renaissance | 207.60K | 0.31% | $126.41K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Novo | 2.51M | 0.06% | $912.27K |
| Ikarian capital | 1.53M | 0.06% | $554.05K |
| Alyeska investment group | 987.65K | 0.01% | $1.16M |
| Xtx topco | 179.21K | 0.00% | $65.07K |
| Boothbay fund management | 591.18K | 0.00% | $214.66K |
| Pks advisory services | 20.00K | 0.00% | $12.18K |
| Gsa capital partners llp | 348.35K | 0.00% | $20.00K |
| Hilton capital management | 25.51K | 0.00% | $15.53K |
| Virtu financial | 39.06K | 0.00% | $14.00K |
| Bridgeway capital management | 75.00K | 0.00% | $27.23K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ikarian capital | 1.53M | 0.06% | 1.53M |
| Boothbay fund management | 591.18K | 0.00% | 591.18K |
| Gsa capital partners llp | 348.35K | 0.00% | 348.35K |
| Point72 asset management | 250.00K | 0.00% | 250.00K |
| Xtx topco | 179.21K | 0.00% | 150.02K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vivo capital | - | - | -6.17M |
| Samsara biocapital | - | - | -3.64M |
| Pfm health sciences, lp | - | - | -1.97M |
| Armistice capital | - | - | -1.54M |
| Marshall wace, llp | 1.05M | 0.00% | -1.05M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 1.53M | 0.06% | 1.53M | $554.05K |
| Boothbay fund management | 591.18K | 0.00% | 591.18K | $214.66K |
| Gsa capital partners llp | 348.35K | 0.00% | 348.35K | $20.00K |
| Point72 asset management | 250.00K | 0.00% | 250.00K | $90.78K |
| Quadrature capital | 83.38K | 0.00% | 83.38K | $30.28K |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -122.00 |
| Advisor group | -230.00 |
| Raymond james financial | -1.00K |
| Redwood wealth management group | -4.17K |
| Two sigma securities | -10.38K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | -57.14% | 1,410,085 | -85.75% | 2 | 0.93% | 3 | -78.57% | 3 | -40.00% |
| Sep 30, 2025 | 20 | -16.67% | 9,870,183 | -43.60% | 14 | 2.12% | 13 | 18.18% | 5 | -16.67% |
| Jun 30, 2025 | 26 | 23.81% | 18,182,707 | -4.64% | 27 | 3.29% | 11 | 175.00% | 8 | - |
| Mar 31, 2025 | 1 | -96.15% | 23,717 | -99.88% | - | 0.00% | 1 | -92.31% | - | -100.00% |
| Dec 31, 2024 | 12 | -36.84% | 9,874,693 | -58.14% | 14 | 1.17% | 7 | -12.50% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| HBM Healthcare Investments AG Ord | 3.94M | 5.48% | - |
| MEDICAL BioHealth EUR Acc | 679.10K | 1.03% | 7.40K |
| Fidelity Select Biotechnology | 314.60K | 0.48% | - |
| Abante Quant Value FI | 218.78K | 0.30% | - |
| Protea Sectoral Biotech Opps IF USD Acc | 91.44K | 0.14% | - |
| Bridgeway Ultra-Small Company Market | 75.00K | 0.10% | - |
| Fidelity Nasdaq Composite Index | 33.31K | 0.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 30, 2025 | Hunter Heidi | - | Buy | $20.88K |
| Dec 23, 2024 | Ahmad Qasim Iftikhar | Chief Medical Officer | Buy | $26.55K |
| Dec 23, 2024 | Zocca Mai-Britt | Chief Executive Officer | Buy | $10.12K |
| Dec 23, 2024 | Sullivan Amy | Chief Financial Officer | Buy | $8.48K |
| Dec 23, 2024 | Smith Devin Whittemore | General Counsel | Buy | $9.72K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 1 | - |
| 2024 Q4 | 4 | - |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 1 |
IOBT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools